The Hair Loss Encyclopedia

Search

for
Search:

GlossaryRituximab

monoclonal antibody targeting CD20 protein on B-cells

Rituximab, also known as Rituxan, is a monoclonal antibody used to treat certain autoimmune diseases and types of cancer, such as non-Hodgkin's lymphoma and chronic lymphocytic leukemia. It works by targeting and binding to the CD20 protein found on the surface of B-cells, leading to their destruction, which helps in reducing the abnormal immune response or cancerous growth.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 258 results

Cyclophosphamide and Rituximab in Frequently Relapsing/Steroid-Dependent Nephrotic Syndrome

research Cyclophosphamide and Rituximab in Frequently Relapsing/Steroid-Dependent Nephrotic Syndrome

39 citations, November 2015 in “Pediatric Nephrology”

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Severe Steroid-Dependent Idiopathic Angioedema with Response to Rituximab

research Severe Steroid-Dependent Idiopathic Angioedema with Response to Rituximab

16 citations, August 2011 in “Annals of Allergy Asthma & Immunology”

A woman with severe angioedema improved significantly after treatment with rituximab.

Rituximab for Bone Lymphoma

research Rituximab for Bone Lymphoma

5 citations, June 2001 in “Annals of Internal Medicine”

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

Successful Treatment of Alopecia Universalis with Rituximab Therapy

research Successful Treatment of Alopecia Universalis with Rituximab Therapy

April 2020 in “Rheumatology”

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

research Reply to 'Regarding the Risk Factors of Rituximab-Induced Thrombocytopenia in Patients with Autoimmune Bullous Diseases'

June 2024 in “The Journal of Dermatology”

View more "rituximab" in research →

Community Join

0 / 0 results

— no results